Skip to content
Business Strategy
Technology Platform
Pipeline
News & Media
Careers
About Us
Investor Relations
Business Strategy
Oral Peptide
Opportunities
Technology Platform
MIRA/JE®
Oral Delivery Challenges
About Us
Company history
Business overview
Core products
Management Team
Pipeline
Overview
ANY 002
ANY 004
Shareholders' Meeting Information
Major shareholders and the distribution of ownership
Annual report of the shareholders' meeting
Notice of shareholders' meeting, agenda booklet, and related conference materials
Minutes of the shareholders' meeting
Financial information
Financial statements
Important information announcement
Corporate briefing sessions held for information and presentations or audio-visual files
Dividend and share price information
Dividend and share price information
Bond issuance operations
Bond issuance operations
Corporate Governance
Board organization
Duties of the Board of Directors
Corporate governance structure
Company Charter and Regulations
Corporate Social Responsibility
Corporate Social Responsibility Vision
Risk management policies
Climate change response measures
Stakeholders
Stakeholder policy
繁中
ENG
繁中
ENG
Contact Us
Home
/
Contact Us
Contact Us
奧孟亞股份有限公司
電話|(02)2655-8988
信箱|info@anyabiopharm.com
地址|115603 台北市南港區園區街 3-2 號 4 樓
繁中
ENG
繁中
ENG
Contact Us
Business Strategy
Oral Peptide
Opportunities
Technology Platform
MIRA/JE®
Oral Delivery Challenges
Pipeline
Overview
ANY 002
ANY 004
Careers
Careers
About Us
Company history
Business overview
Core products
Management Team
Shareholders' Meeting Information
Major shareholders and the distribution of ownership
Annual report of the shareholders' meeting
Notice of shareholders' meeting, agenda booklet, and related conference materials
Minutes of the shareholders' meeting
Financial information
Financial statements
Important information announcement
Corporate briefing sessions held for information and presentations or audio-visual files
Dividend and share price information
Dividend and share price information
Bond issuance operations
Bond issuance operations
Corporate Governance
Board organization
Duties of the Board of Directors
Corporate governance structure
Company Charter and Regulations
Corporate Social Responsibility
Corporate Social Responsibility Vision
Risk management policies
Climate change response measures
Stakeholders
Stakeholder policy
News
All
Important information
Breakthrough oral peptide lowers absorption barrier! Omonya ANY004 Phase I clinical trial obtains positive human data
2026.10.01
Important information
Technology Enterprise Approval Letter: MIRA/JE® Platform Officially Recognized, Marking a Key Milestone Toward IPO
2026.07.24
Important information
Partnering with the international-class GMP manufacturer OPA Biotechnology! ANY002 mini expands its production footprint in the US, Japan, and Taiwan
2026.04.28
Important information
Aggressive expansion into the international oral GLP-1 market! ANY004 clinical phase 1 trial launched in Australia
2026.03.02